Fig. 1From: Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labelingQuantification of human Aβ1–38 (A), Aβ1–40 (B), Aβ1–42 (C) and tau (D) in the CSF of 13-month and 21-month old rats (13 months: APP/Tau: n = 16, ntg: n = 2; 21 months: APP/Tau: n = 14, ntg: n = 4). Bars represent mean ± SD; ***p < 0.001, one-way ANOVA followed by Tukey’s multiple comparison testBack to article page